Name : Mohammad Zaid Khan (27Y/M)

Date : 07 May 2024

Test Asked : Rbs, Hcl Tasl Annual Health Check + 3 Others

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL , 10, JIGANI INDUSTRIAL AREA, JIGANI, , BENGALURU,
TEST ASKED : RBS,HCL TASL ANNUAL HEALTH CHECK,HBA,HEMOGRAM - KARNATAKA, INDIA,
6 PART (DIFF),COMPLETE URINE ANALYSIS

MOBILE NO : PAN ID :
DOB :

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
PLATELET TO LARGE CELL RATIO(PLCR) 18.8 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.2 % 11.6-14
TOTAL RBC 5.73 X 10^6/µL 4.5-5.5
LIPID
HDL / LDL RATIO 0.27 Ratio > 0.40
LDL / HDL RATIO 3.7 Ratio 1.5-3.5
LDL CHOLESTEROL - DIRECT 193 mg/dL < 100
NON-HDL CHOLESTEROL 228.49 mg/dL < 160
TC/ HDL CHOLESTEROL RATIO 5.4 Ratio 3-5
TOTAL CHOLESTEROL 281 mg/dL < 200
TRIG / HDL RATIO 3.73 Ratio < 3.12
TRIGLYCERIDES 196 mg/dL < 150
LIVER
ALANINE TRANSAMINASE (SGPT) 131.1 U/L < 45
ASPARTATE AMINOTRANSFERASE (SGOT ) 83 U/L < 35
BILIRUBIN (INDIRECT) 1.07 mg/dL 0-0.9
BILIRUBIN - TOTAL 1.25 mg/dL 0.3-1.2
PROTEIN - TOTAL 8.51 gm/dL 5.7-8.2
SERUM GLOBULIN 3.72 gm/dL 2.5-3.4

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL , 10, JIGANI INDUSTRIAL AREA, JIGANI, ,
BENGALURU, KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH

PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :

TEST NAME TECHNOLOGY VALUE UNITS

RANDOM BLOOD SUGAR(GLUCOSE) PHOTOMETRY 84.6 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Random/Post-Prandial Plasma

Glucose (RPG/PPPG)

Normal 70 to 140 mg/dl

Impaired Glucose 140 - 199 mg/dl

Tolerance

Diabetes Greater than or Equal to 200

mg/dl
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 18:27
Report Released on (RRT) : 07 May 2024 19:12
Sample Type : FLUORIDE NF
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0705098046/HCL72
Barcode : CF651824 Page : 1 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY , 10, JIGANI INDUSTRIAL AREA, JIGANI, ,
: HCL
BENGALURU, KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 5.4 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 108 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 18:36

Report Released on (RRT) : 07 May 2024 19:32
Sample Type : EDTA
Labcode : 0705098486/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CG912755
Page : 2 of 12
 PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL , 10, JIGANI INDUSTRIAL AREA, JIGANI, ,
BENGALURU, KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) HF & FC 8.24 X 10³ / µL 4.0 - 10.0
NEUTROPHILS Flow Cytometry 70.3 % 40-80
LYMPHOCYTE Flow Cytometry 20.9 % 20-40
MONOCYTES Flow Cytometry 4.9 % 2-10
EOSINOPHILS Flow Cytometry 2.9 % 1-6
BASOPHILS Flow Cytometry 0.7 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) Flow Cytometry 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT Calculated 5.79 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT Calculated 1.72 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT Calculated 0.4 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT Calculated 0.06 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT Calculated 0.24 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) Calculated 0.02 X 10³ / µL 0-0.3
TOTAL RBC HF & EI 5.73 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS Calculated 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % Flow Cytometry 0.01 % 0.0-5.0
HEMOGLOBIN SLS-Hemoglobin Method 15.8 g/dL 13.0-17.0
HEMATOCRIT(PCV) CPH Detection 49.3 % 40.0-50.0
MEAN CORPUSCULAR VOLUME(MCV) Calculated 86 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) Calculated 27.6 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) Calculated 32 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 44.4 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) Calculated 14.2 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) Calculated 9.6 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) Calculated 9.2 fL 6.5-12
PLATELET COUNT HF & EI 323 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) Calculated 18.8 % 19.7-42.4
PLATELETCRIT(PCT) Calculated 0.3 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 18:36
Report Released on (RRT) : 07 May 2024 19:32
Sample Type : EDTA
Labcode : 0705098486/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CG912755 Page : 3 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

, 10, JIGANI INDUSTRIAL AREA, JIGANI, ,
REF. BY : HCL
BENGALURU, KARNATAKA, INDIA,
TEST ASKED : COMPLETE URINE ANALYSIS

PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.
Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.02 - 1.003-1.030
PH pH indicator 6.5 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy 1 cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:23
Report Released on (RRT) : 07 May 2024 20:14
Sample Type : URINE
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0705100325/HCL72
Barcode : CF525502 Page : 4 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

, 10, JIGANI INDUSTRIAL AREA, JIGANI, , BENGALURU,
REF. BY : HCL KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :
TEST NAME TECHNOLOGY VALUE UNITS
HEPATITIS B SURFACE ANTIGEN (HBSAG) E.C.L.I.A 0.38 OD ratio
Non reactive: < 0.90
Border line : >=0.90 to < 1.0
Reactive : >= 1.0

Clinical Significance:
Hepatitis B Surface Antigen test is a screening test and is being performed using solid phase enzyme immunoassay. A
positive report does not confirm diagnosis and all positive cases should be confirmed by confirmatory test like PCR.
Type B viral hepatitis is usually accompanied by the appearance of hepatitis B surface antigen in the serum. HBsAg
can be detected in the serum as early as 2 to 3 weeks before the onset of the illness and reaches a peak titre at the
time when the characteristic symptoms like jaundice and changes in the liver-specific enzymes appear. This is normally
followed by a gradual elimination of the antigen. In some cases and in an unknown percentage of subclinical hepatitis b
virus infections, the antigen can be detected in the serum for years, if not for life. Despite the high sensitivity of
HBsAg assays, a risk of the transmission of hepatitis B by an HBsAg -negative sample cannot be ruled out.

Specifications:
Precision: Intra assay (%CV): 14.6 %, Inter assay (%CV): 11.6 % ,Sensitivity: 99.90%; Specificity:100%

Kit validation references: Proposal for the validation of Anti HIV 1/2 or HIV Ag/Ab combination Assays Anti HCV Assays
HBsAg and Anti HBc assay for Use with cadaveric Samples PEI 08/05/2014.

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Labcode : 0705099424/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CI912610 Page : 5 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY , 10, JIGANI INDUSTRIAL AREA, JIGANI, , BENGALURU,
: HCL
KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 281 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 52 mg/dL 40-60
TRIGLYCERIDES PHOTOMETRY 196 mg/dL < 150
LDL CHOLESTEROL - DIRECT PHOTOMETRY 193 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO CALCULATED 5.4 Ratio 3-5
TRIG / HDL RATIO CALCULATED 3.73 Ratio < 3.12
LDL / HDL RATIO CALCULATED 3.7 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.27 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 228.49 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 39.12 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
TRIG - Enzymatic, End Point
LDL - Direct Measure
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Labcode : 0705099424/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CI912610 Page : 6 of 12

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY , 10, JIGANI INDUSTRIAL AREA, JIGANI, , BENGALURU,
: HCL
KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
ALKALINE PHOSPHATASE PHOTOMETRY 96.4 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 1.25 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.18 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 1.07 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 25.9 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 83 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 131.1 U/L < 45
SGOT / SGPT RATIO CALCULATED 0.63 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 8.51 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.79 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.72 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.29 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Labcode : 0705099424/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CI912610 Page : 7 of 12

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY , 10, JIGANI INDUSTRIAL AREA, JIGANI, , BENGALURU,
: HCL
KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
CREATININE - SERUM PHOTOMETRY 0.86 mg/dL 0.72-1.18
URIC ACID PHOTOMETRY 7 mg/dL 4.2 - 7.3
Please correlate with clinical conditions.

Method :
SCRE - Creatinine Enzymatic Method
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Labcode : 0705099424/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CI912610 Page : 8 of 12

 PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

, 10, JIGANI INDUSTRIAL AREA, JIGANI, , BENGALURU,
REF. BY : HCL
KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH
CHECK,HEMOGRAM
PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 136 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 5.99 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 1.13 µIU/mL 0.54-5.30

Comments : SUGGESTING THYRONORMALCY

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Labcode : 0705099424/HCL72 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CI912610 Page : 9 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL , 10, JIGANI INDUSTRIAL AREA, JIGANI, ,
BENGALURU, KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH

PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :

TEST NAME TECHNOLOGY VALUE UNITS

BLOOD UREA PHOTOMETRY 33.5 mg/dL
Bio. Ref. Interval. :-

ADULT 17 - 43
NEWBORN 8.4 - 25.8
INFANT/CHILD 10.8 - 38.4

CLINICAL SIGNIFICANCE :
Urea is Nitrogenous waste product formed after protein breakdown. Rise in Urea levels leads to Uremia which may cause Kidney
failure. Urea levels may be elevated due to renal causes such as acute glomerulonephritis, chronic nephritis, polycystic kidney,
tubular necrosis and nephrosclerosis.

Please correlate with clinical conditions.

Method:- KINETIC UV ASSAY.

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0705099424/HCL72
Barcode : CI912610 Page : 10 of 12
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MOHAMMAD ZAID KHAN (27Y/M) SAMPLE COLLECTED AT :

REF. BY : HCL , 10, JIGANI INDUSTRIAL AREA, JIGANI, ,
BENGALURU, KARNATAKA, INDIA,
TEST ASKED : BLOOD SUGAR (RANDOM),COMPLETE URINE
ANALYSIS,HbA1c,HCL TASL ANNUAL HEALTH

PATIENTID : MK23735280
MOBILE NO : PAN ID :
DOB :

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 119 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 07 May 2024 08:00

Sample Received on (SRT) : 07 May 2024 19:07
Report Released on (RRT) : 07 May 2024 22:13
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0705099424/HCL72
Barcode : CI912610 Page : 11 of 12
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of
technologies should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.

EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

Page : 12 of 12